Silibinin as potential tool against SARS‐Cov ‐2: In silico spike receptor‐binding domain and main protease molecular docking analysis, and in vitro endothelial protective effects-Reference-Cited by-同舟云学术

Silibinin as potential tool against SARS‐Cov ‐2: In silico spike receptor‐binding domain and main protease molecular docking analysis, and in vitro endothelial protective effects

Published:2021-04-06 Issue:8 Volume:35 Page:4616-4625
ISSN:0951-418X
Container-title:Phytotherapy Research
language:en
Short-container-title:Phytotherapy Research

Author:

Speciale Antonio¹^ORCID,Muscarà Claudia¹^ORCID,Molonia Maria Sofia¹^ORCID,Cimino Francesco¹^ORCID,Saija Antonella¹^ORCID,Giofrè Salvatore Vincenzo¹^ORCID

Affiliation:

1. Dipartimento di Scienze Chimiche, Biologiche, Farmaceutiche ed Ambientali Università di Messina Messina Italy

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ptr.7107

Reference45 articles.

1. The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management

2. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

3. Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow’s triad